Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor Patients (SARMETA)

This study has been completed.
Information provided by (Responsible Party):
Sanofi Identifier:
First received: July 24, 2012
Last updated: February 16, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2016
  Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)